Pseudo-peptides in drug discovery: A newer technology
Abstract
Drug
discovery is devoted to the topic and draws together knowledge gained on
different types of peptidomimetics and other pseudo-peptides with drug properties.
It includes peptoides (N-substituted oligo-glycines) beta-peptides, gamma-peptides,
pyrrole-imidazole polyamides, DNA-like peptide nucleic acids, Alpha-helical
peptide nucleic acids, DNA-cleaving pseudo-peptides in DNA binders as well as
peptide nucleic acids. Peptides are among the most versatile bioactive
molecules, yet they do not make good drugs, because they are quickly degraded
or modified in thebody. Thus, drug discovery has turned to the novel field of
peptidomimetics to design non-peptide compounds mimicking the pharmacophore and
thus the activity of the original peptide. These novel compounds open up new
perspectives in drug design by providing an entire range of highly specific
pharmaceuticals that have a high bioavailability. Peptides are among the most
versatile bioactive molecules, yet the donot make good drugs, because they are
quickly degraded or modified in the body.

Comments
Post a Comment